Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumMadness: An Educational Tournament

David L. Leverenz, MD, Akrithi Udupa, MD, Guy Katz, MD, Didem Saygin, MD, Christopher Witt, MD, Lisa G. Criscione-Schreiber, MD, MEd, & Matthew A. Sparks, MD  |  Issue: July 2021  |  July 15, 2021

Figure 2: Tweet About It

Figure 2: Tweet About It
This figure shows the number of tweets per day using the hashtag #RheumMadness during the 2021 tournament. Data from Symplur.

impressions, or the number of times a tweet about #RheumMadness appears in any Twitter user’s feed. In 2021, RheumMadness led to 2,312,386 potential Twitter impressions (data from Symplur, 2/8/21–4/8/21).

What do RheumMadness participants tweet about? Participants share their perspectives on concepts in the tournament, joke and connect with each other, rejoice when their bracket performs well, and commiserate when their bracket performs poorly.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Particularly memorable moments from the 2021 tournament included rheumatology participants educating a nephrologist about the importance of the newly identified and described VEXAS syndrome, authors of studies included in the tournament chiming in with their own insights, and a Twitter poll created by a participant asking rheumatologists if the black box warning for febuxostat should be modified or removed based on the findings of the Febuxostat versus Allopurinol Streamlined Trial (FAST). A word cloud of trending terms from Twitter conversations during the tournament provides a glimpse into the social interactions in RheumMadness (see Figure 3).

Figure 3: Trending Terms

Figure 3: Trending Terms
This word cloud illustrates the terms that trended on Twitter during the RheumMadness 2021 tournament, excluding tweets from @DavidLeverenz (tournament organizer) and all retweets. Data from Symplur.

We also created a private Rheum­Madness Facebook group just for rheumatology trainees, hypothesizing that trainees might feel more comfortable sharing their thoughts and opinions with peers in a private space, rather than broadly on Twitter. Although we did garner 81 members in the Facebook group, there was surprisingly little interaction on Facebook compared with Twitter. Therefore, moving forward, Twitter will continue to serve as the main social space for connection in RheumMadness.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With the knowledge that podcasts help foster a sense of connection in professional communities, we created a RheumMadness podcast series, hosted by the RheumMadness Leadership Team, all of whom are authors of this article.5 The composition of this team is intended to reflect the target audience for RheumMadness, ranging from fully trained rheumatologists to those aspiring to become rheumatologists.

Listeners are invited to journey with us through each stage of RheumMadness. In our first episodes, we discussed teams that could be included in the bracket to familiarize listeners with the concept of rheumatology topics playing as teams in the tournament while also providing direct teaching about the topics.

After announcing the 2021 bracket of teams, we recorded two bracketology episodes, discussing how each team might do in the tournament, thus providing context for the type of conversation we hoped RheumMadness might foster online.

In our final two episodes, we reflected on the results of the tournament and thanked everyone involved. In total, we recorded 15 podcast episodes from August 2020 through April 2021, generating more than 2,300 total downloads, an average of 153 downloads per episode.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Education & Training Tagged with:online educationRheumMadness

Related Articles

    An Oral Targeted Therapy: RheumMadness 2022 Pim Kinases Scouting Report

    February 8, 2022

    According to research, Pim kinases contribute to the pathogenesis of rheumatoid arthritis (RA) and may have the therapeutic potential for inhibition in patients with RA.

    Conversation: RheumMadness 2022 Reproductive Health Guide Scouting Report

    March 2, 2022

    Rheumatologists play a critical role in the reproductive health of their patients, but only half of rheumatologists currently ask their patients about reproductive health or family planning issues. A new guideline seeks to change that.

    In the Bones: RheumMadness 2022 False Positive MRI in Axial SpA

    March 3, 2022

    Spondyloarthropathy (SpA) can be difficult to diagnose, with rheumatologists sometimes relying on classification criteria designed for clinical trials. Research examines how the use of MRIs affects the finding of bone marrow edema and the diagnosis of axial SpA.

    Beyond Trial & Error: RheumMadness 2022 AI: TNFi Response Scouting Report

    February 14, 2022

    As the capabilities of machine learning and artificial intelligence improve, rheumatologists have access to more data than ever, which may enable them to better predict which patients will respond to specific treatments, such as tumor necrosis factor inhibitors.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences